irinotecan
Showing 26 - 50 of 493
Hepatocellular Carcinoma Trial (Irinotecan, Sonidegib, Sorafenib)
Not yet recruiting
- Hepatocellular Carcinoma
- Irinotecan
- +2 more
- (no location specified)
Dec 20, 2022
Colorectal Cancer, Pancreatic Cancer Trial (Irinotecan)
Recruiting
- Colorectal Cancer
- Pancreatic Cancer
- Irinotecan
-
Lexington, KentuckyUniversity of Kentucky
Oct 13, 2022
Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinomas
- SI-B001
- Irinotecan
-
Beijing, Beijing, ChinaBeijing Cancer Hostital
Mar 14, 2022
Metastatic Colorectal Cancer Trial in Shanghai (Anlotinib, Penpulimab, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer
- Anlotinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)
Recruiting
- Adenocarcinoma
- +9 more
- Nab-paclitaxel
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 15, 2022
Gastric Cancer, Peritoneal Metastases Trial in Rotterdam (Irinotecan, CAPOX)
Recruiting
- Gastric Cancer
- Peritoneal Metastases
- Irinotecan
- CAPOX
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 15, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction Trial in France (Regorafenib and Irinotecan,
Terminated
- Adenocarcinoma of the Stomach
- Adenocarcinoma of the Gastroesophageal Junction
- Regorafenib and Irinotecan
- Irinotecan
-
Angers, France
- +26 more
Jul 26, 2022
Mismatch Repair-proficient, Colorectal Cancer Metastatic, Microsatellite Stable Trial in Hangzhou (Tislelizumab, Irinotecan,
Recruiting
- Mismatch Repair-proficient
- +2 more
- Tislelizumab
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 17, 2021
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)
Active, not recruiting
- Gastric Adenocarcinoma
- GastroEsophageal Cancer
- TAS-102
- Irinotecan
-
Orange, California
- +1 more
Apr 4, 2022
Ewing Sarcoma Trial in United States (drug, diagnostic test, other)
Recruiting
- Ewing Sarcoma
- Trabectedin 1 MG [Yondelis]
- +3 more
-
Los Angeles, California
- +5 more
Aug 15, 2022
Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)
Recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +4 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022
Relapsed Solid Tumors, Refractory Solid Tumors Trial in Aurora, Lexington, Dallas (Eribulin, Irinotecan, Cefixime)
Completed
- Relapsed Solid Tumors
- Refractory Solid Tumors
- Eribulin
- +2 more
-
Aurora, Colorado
- +2 more
Jan 31, 2022
Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Anlotinib Plus Irinotecan, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Anlotinib Plus Irinotecan
- Irinotecan
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Aug 30, 2021
Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)
Withdrawn
- Solid Tumor Malignancy
- Selinexor
- Irinotecan
-
Hackensack, New JerseyJohn Theurer Cancer Center at HackensackUMC
Dec 14, 2021
Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)
Recruiting
- Metastatic Pancreatic Cancer
- Nab-paclitaxel
- +6 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 14, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- +3 more
- (no location specified)
May 5, 2022
Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)
Not yet recruiting
- Solid Tumor
- Atezolizumab
- +3 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Aug 30, 2022
Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)
Recruiting
- Neoplasms
- +2 more
- Ramucirumab
- +7 more
-
Leiden, NetherlandsLeids Universitair Medisch Centrum
Aug 14, 2023